• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Sep8
Kintai Therapeutics Completes Enrollment for KT-939 Long-Term Safety Trial
22:19
Aug28
Kehua Pharmaceutical-B Announces Wider Loss in Semi-annual Results
15:59
KINTOR PHARMA-B released FY2025 Q1 earnings on August 28, 2025 (BJT) with actual revenue of HKD 3.204 M and EPS of HKD -0.1027
15:00
KINTOR PHARMA-B released FY2025 Q2 earnings on August 28 After-Market (BJT), actual revenue HKD 3.275 M, actual EPS HKD -0.1049
11:00
KINTOR PHARMA-B released FY2025 Semi-Annual earnings on August 28 After-Market (BJT), actual revenue HKD 6.479 M, actual EPS HKD -0.2077
11:00
Aug20
KINTOR PHARMA-B to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)
01:57

Schedules & Filings

Schedules
Filings
Aug28
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 3.275 M, Net Income -45.57 M, EPS -0.1049

Mar26
Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 2.66 M, Net Income -44.57 M, EPS -0.1034

Aug26
Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -38.41 M, EPS -0.0892

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
06108
0.315
+28.05%
+0.069
08003
0.160
+28.00%
+0.035
01166
0.740
+27.59%
+0.160
02320
0.088
+25.71%
+0.018
08412
0.450
+25.00%
+0.090
08100
0.350
+25.00%
+0.070
00310
0.175
+23.24%
+0.033
02349
0.075
+20.97%
+0.013
02289
6.090
+18.71%
+0.960
00723
0.325
+18.18%
+0.050
View More